Your cart is currently empty!
Dr. Kimberly Ehman joined NAMSA in March 2025 after the acquisition of WuXi AppTec’s U.S. Medical Device Testing operations. She had been with WuXi AppTec since 2020 and brings over 18 years of experience in toxicology and medical device testing.
As Director, Regulatory Toxicology, Dr. Ehman provides expertise in toxicological risk assessments for medical devices, food and beverage products, and electronic nicotine delivery systems. She supports medical device manufacturers and suppliers with technical and regulatory guidance for biocompatibility test programs and conducts quantitative toxicological risk assessments to ensure product safety and compliance.
Dr. Ehman earned her Ph.D. in parasitology from McGill University and conducted postdoctoral research at the U.S. EPA in developmental neurotoxicology.
